XML 24 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Operating Activities    
Net Income $ 240 $ 274
Net Income (Loss) 247 273
Adjustments to reconcile Net Income to net cash from operating activities:    
Depreciation and amortization 229 209
Nuclear fuel amortization 15 13
Allowance for equity funds used during construction (5) (5)
Deferred income taxes 80 84
Equity earnings of equity method investees (15) (16)
Dividends from equity method investees 18 16
Asset (gains) losses and impairments, net 0 (10)
Changes in assets and liabilities:    
Accounts receivable, net 97 (8)
Inventories 143 172
Accounts payable (93) (123)
Gas inventory equalization 87 130
Accrued pension liability (3) 2
Accrued postretirement liability (29) (135)
Derivative assets and liabilities 40 49
Regulatory assets and liabilities 34 (4)
Other current and noncurrent assets and liabilities (97) 99
Net cash from operating activities 741 747
Investing Activities    
Plant and equipment expenditures — utility (394) (366)
Plant and equipment expenditures — non-utility (30) (39)
Acquisition 0 (240)
Proceeds from sale of assets 0 13
Restricted cash for debt redemption, principally Securitization, net 0 96
Proceeds from sale of nuclear decommissioning trust fund assets 260 246
Investment in nuclear decommissioning trust funds (262) (250)
Distributions from equity method investees 3 3
Contributions to equity method investees (26) (22)
Other 12 3
Net cash used for investing activities (437) (556)
Financing Activities    
Issuance of long-term debt, net of issuance costs 0 495
Redemption of long-term debt (11) (117)
Short-term borrowings, net (134) (398)
Issuance of common stock 0 9
Repurchase of common stock (33) 0
Dividends on common stock (131) (122)
Other 3 (7)
Net cash from (used for) financing activities (306) (140)
Net Increase (Decrease) in Cash and Cash Equivalents (2) 51
Cash and Cash Equivalents at Beginning of Period 37 48
Cash and Cash Equivalents at End of Period 35 99
Supplemental disclosure of non-cash investing and financing activities    
Plant and equipment expenditures in accounts payable 134 186
DTE Electric    
Operating Activities    
Net Income (Loss) 127 137
Adjustments to reconcile Net Income to net cash from operating activities:    
Depreciation and amortization 176 155
Nuclear fuel amortization 15 13
Allowance for equity funds used during construction (4) (5)
Deferred income taxes 70 76
Changes in assets and liabilities:    
Accounts receivable, net 57 (3)
Inventories 31 2
Accounts payable 25 (8)
Accrued pension liability — affiliates 3 (88)
Accrued postretirement liability — affiliates (19) (128)
Regulatory assets and liabilities 40 (43)
Other current and noncurrent assets and liabilities (68) 65
Net cash from operating activities 453 173
Investing Activities    
Plant and equipment expenditures (315) (311)
Acquisition 0 (240)
Proceeds from sale of assets 6 0
Restricted cash for debt redemption, principally Securitization, net 0 96
Notes receivable from affiliate 0 8
Proceeds from sale of nuclear decommissioning trust fund assets 260 246
Investment in nuclear decommissioning trust funds (262) (250)
Transfer of Rabbi Trust assets to affiliate 0 137
Other 14 2
Net cash used for investing activities (297) (312)
Financing Activities    
Issuance of long-term debt, net of issuance costs 0 496
Redemption of long-term debt (10) (115)
Short-term borrowings, net — affiliate 22 (49)
Short-term borrowings, net — other (61) (50)
Dividends on common stock (105) (99)
Other 0 (4)
Net cash from (used for) financing activities (154) 179
Net Increase (Decrease) in Cash and Cash Equivalents 2 40
Cash and Cash Equivalents at Beginning of Period 15 14
Cash and Cash Equivalents at End of Period 17 54
Supplemental disclosure of non-cash investing and financing activities    
Plant and equipment expenditures in accounts payable $ 100 $ 154